Chat V, Dagayev S, Moran U, Snuderl M, Weber J, Ferguson R
Front Oncol. 2023; 12:1050741.
PMID: 36741706
PMC: 9894711.
DOI: 10.3389/fonc.2022.1050741.
Liu F, Li S
Front Pharmacol. 2022; 13:934396.
PMID: 36034860
PMC: 9399465.
DOI: 10.3389/fphar.2022.934396.
Pecorelli A, Valacchi G
Cancers (Basel). 2022; 14(13).
PMID: 35804995
PMC: 9265047.
DOI: 10.3390/cancers14133224.
Sanchez-Sendra B, Gonzalez-Munoz J, Perez-Deben S, Monteagudo C
Cancers (Basel). 2022; 14(6).
PMID: 35326682
PMC: 8946551.
DOI: 10.3390/cancers14061532.
Rivera H, Munoz E, Osuna D, Florez M, Carvajal M, Alberto Gomez L
Int J Mol Sci. 2021; 22(4).
PMID: 33562431
PMC: 7914888.
DOI: 10.3390/ijms22041591.
MicroRNA-193b regulates human ovarian cancer cell growth via targeting STMN1.
Li H, Xu Y, Zhao D
Exp Ther Med. 2020; 20(4):3310-3315.
PMID: 32855702
PMC: 7444320.
DOI: 10.3892/etm.2020.9033.
Melanoma-Derived Exosomal miR-125b-5p Educates Tumor Associated Macrophages (TAMs) by Targeting Lysosomal Acid Lipase A (LIPA).
Gerloff D, Lutzkendorf J, Moritz R, Wersig T, Mader K, Muller L
Cancers (Basel). 2020; 12(2).
PMID: 32079286
PMC: 7072270.
DOI: 10.3390/cancers12020464.
Association between microRNA-125b expression in formalin-fixed paraffin-embedded tumor tissues and prognosis in patients with melanoma.
Yan J, Jiang Q, Lu H, Na S, Long S, Xin Y
Oncol Lett. 2019; 18(2):1856-1862.
PMID: 31423254
PMC: 6607191.
DOI: 10.3892/ol.2019.10506.
MiR-125b Suppression Inhibits Apoptosis and Negatively Regulates Sema4D in Avian Leukosis Virus-Transformed Cells.
Ren C, Xie R, Yao Y, Yu M, Chang F, Xing L
Viruses. 2019; 11(8).
PMID: 31394878
PMC: 6723722.
DOI: 10.3390/v11080728.
MicroRNA-218 regulates the chemo-sensitivity of cervical cancer cells through targeting survivin.
Yu M, Xu B, Yang H, Xue S, Zhang R, Zhang H
Cancer Manag Res. 2019; 11:6511-6519.
PMID: 31372052
PMC: 6636183.
DOI: 10.2147/CMAR.S199659.
MicroRNA-138 negatively regulates the hypoxia-inducible factor 1α to suppress melanoma growth and metastasis.
Qiu H, Chen F, Chen M
Biol Open. 2019; 8(8).
PMID: 31371307
PMC: 6737980.
DOI: 10.1242/bio.042937.
Interplay between small and long non-coding RNAs in cutaneous melanoma: a complex jigsaw puzzle with missing pieces.
Riefolo M, Porcellini E, Dika E, Broseghini E, Ferracin M
Mol Oncol. 2018; 13(1):74-98.
PMID: 30499222
PMC: 6322194.
DOI: 10.1002/1878-0261.12412.
Downregulation of intratumoral expression of miR-205, miR-200c and miR-125b in primary human cutaneous melanomas predicts shorter survival.
Sanchez-Sendra B, Martinez-Ciarpaglini C, Gonzalez-Munoz J, Murgui A, Terradez L, Monteagudo C
Sci Rep. 2018; 8(1):17076.
PMID: 30459436
PMC: 6244285.
DOI: 10.1038/s41598-018-35317-3.
The functional mechanism of miR-125b in gastric cancer and its effect on the chemosensitivity of cisplatin.
Zhang X, Yao J, Guo K, Huang H, Huai S, Ye R
Oncotarget. 2018; 9(2):2105-2119.
PMID: 29416757
PMC: 5788625.
DOI: 10.18632/oncotarget.23249.
Tensor decomposition-based unsupervised feature extraction applied to matrix products for multi-view data processing.
Taguchi Y
PLoS One. 2017; 12(8):e0183933.
PMID: 28841719
PMC: 5571984.
DOI: 10.1371/journal.pone.0183933.
Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing.
Babapoor S, Wu R, Kozubek J, Auidi D, Grant-Kels J, Dadras S
Lab Invest. 2017; 97(6):636-648.
PMID: 28218741
DOI: 10.1038/labinvest.2017.5.
FAK regulates E-cadherin expression via p-SrcY416/p-ERK1/2/p-Stat3Y705 and PPARγ/miR-125b/Stat3 signaling pathway in B16F10 melanoma cells.
Pei G, Lan Y, Chen D, Ji L, Hua Z
Oncotarget. 2017; 8(8):13898-13908.
PMID: 28108732
PMC: 5355148.
DOI: 10.18632/oncotarget.14687.
A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, Cicchillitti L
J Exp Clin Cancer Res. 2016; 35(1):124.
PMID: 27476114
PMC: 4967504.
DOI: 10.1186/s13046-016-0393-0.
Pivotal MicroRNAs in Melanoma: A Mini-Review.
Deng Z, Hao J, Lei D, He Y, Lu L, He L
Mol Diagn Ther. 2016; 20(5):449-55.
PMID: 27351922
DOI: 10.1007/s40291-016-0219-y.
MicroRNAs: New players in cancer prevention targeting Nrf2, oxidative stress and inflammatory pathways.
Zhang C, Shu L, Kong A
Curr Pharmacol Rep. 2015; 1(1):21-30.
PMID: 26618104
PMC: 4659512.
DOI: 10.1007/s40495-014-0013-7.